New compositions based on IGF-binding protein sequences are provided. New
tools for high-throughput research are provided. New methods for the
treatment of human disease are provided. IGFBP-3-derived peptide or small
molecule is administered to subjects having disease, thereby alleviating
the symptoms of the disease.
